Aramchol
Healthy
Phase I
Not Yet Recruiting
Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet
Nov 14, 2025
―
Aramchol Meglumine, Aramchol Free Acid
Healthy
Phase I
Active Not Recruiting
Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets
Jul 09, 2024
―
Aramchol Meglumine
Primary Sclerosing Cholangitis
Phase II
Withdrawn
A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis
Oct 11, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eocene (GPH) have in its pipeline
GPH is currently developing the following drugs: Aramchol, Aramchol Meglumine, Aramchol Free Acid, Aramchol Meglumine. These drug candidates are in various stages of clinical development as the company works toward FDA approval.